טוען...
BET Inhibitors Reduce Cell Size and Induce Reversible Cell Cycle Arrest in AML
Inhibitors of the bromodomain and extra-terminal domain family (BETi) offer a new approach to treating hematological malignancies, with leukemias containing MLL rearrangements being especially sensitive due to a reliance on the regulation of transcription elongation. We explored the mechanism of act...
שמור ב:
| הוצא לאור ב: | J Cell Biochem |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513713/ https://ncbi.nlm.nih.gov/pubmed/30417424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.28005 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|